By Ernie Mundell HealthDay Reporter
TUESDAY, March 19, 2024 — Following the historic reversal of Roe v. Wade in June of 2022, the variety of abortions in the US has risen to greater than 1,000,000 per 12 months, with remedy abortions representing practically two-thirds of these circumstances.
The numbers come from a new report by the Guttmacher Institute, a analysis and coverage group centered on sexual and reproductive well being that helps entry to abortion.
The report discovered an estimated 1,026,690 abortions carried out inside the formal U.S. well being care system throughout 2023 — the primary full calendar 12 months because the Dobbs determination led some states to ban abortion.
That is a ten% rise from 2020 and probably the most abortions seen within the U.S. since 2011, the brand new report famous. By 2023, it discovered, there have been 15.7 abortions per 1,000 girls of reproductive age.
A lot of the rise was linked to a gradual surge in remedy abortions — from 53% of all circumstances in 2020 to 63% by 2023, the institute mentioned. Total, about 642,700 remedy abortions occurred inside the formal well being care system.
In a medicine abortion, girls usually take two medicine, mifepristone and misoprostol, to induce an abortion early in a being pregnant.
“Improved entry to remedy abortion is a optimistic improvement, however it’s not a panacea,” Rachel Jones, Guttmacher principal analysis scientist, mentioned in an announcement from the institute. “As abortion restrictions proliferate post-Dobbs, remedy abortion will be the most viable choice — or the one choice — for some individuals, even when they might have most well-liked in-person procedural care.”
The report additionally discovered that nearly each state with out an abortion ban in place noticed a pointy rise in numbers. Abortions rose by about 25% between 2020 and 2023 in states with out whole abortion bans, the report discovered.
“The sharpest will increase had been seen in states bordering ban states, the place abortions elevated by 37% from 2020 to 2023,” in line with the Guttmacher assertion.
The brand new numbers come forward of oral arguments slated to be heard by the U.S. Supreme Court docket on March 26, concerning continued entry to mifepristone.
“As our newest knowledge emphasize, greater than three out of 5 abortion sufferers in the US use remedy abortion,” Amy Friedrich-Karnik, director of federal coverage on the institute, mentioned within the assertion. “Reinstating outdated and medically pointless restrictions on the availability of mifepristone would negatively impression individuals’s lives and reduce abortion entry throughout the nation.”
In 2021, the U.S. Meals and Drug Administration lifted some restrictions on entry to mifespristone, permitting it to be mailed on to sufferers slightly than having it solely be allotted in-person.
The brand new knowledge relies on Guttmacher’s Month-to-month Abortion Provision Examine, which tracks “abortions offered at brick-and-mortar well being care services (equivalent to clinics or physician’s workplaces) in addition to remedy abortions offered by way of telehealth and digital suppliers situated in the US,” the institute mentioned.
Sources
- Guttmacher Institute, information launch, March 19, 2024
Disclaimer: Statistical knowledge in medical articles present normal tendencies and don’t pertain to people. Particular person elements can differ drastically. All the time search personalised medical recommendation for particular person healthcare selections.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Extra information sources
Subscribe to our e-newsletter
No matter your matter of curiosity, subscribe to our newsletters to get one of the best of Medication.com in your inbox.
